Life extension

Recombinetics Inc. Merges with Makana Therapeutics to Accelerate Xenotransplantation

Retrieved on: 
Thursday, October 8, 2020
Medical specialties, Clinical medicine, Medicine, Organ transplantation, Animal testing, Life extension, Xenotransplantation

Makana Therapeutics will become Recombinetics Inc. newest subsidiary and will be exclusively focused on solving the organ shortage crisis.

Key Points: 
  • Makana Therapeutics will become Recombinetics Inc. newest subsidiary and will be exclusively focused on solving the organ shortage crisis.
  • Recombinetics Inc. and Makana Therapeutics have expertise and strong intellectual property positions in clinical organ transplantation, genetic engineering, reproductive technology, and xenotransplantation.
  • "Recombinetics Inc. deep expertise in porcine genome engineering is a perfect strategic fit for Makana's xenotransplantation expertise," thinks Catherine Thut, outgoing President and CEO of Makana Therapeutics.
  • Under the scientific leadership of Dr. Joe Tector, Makana Therapeutics has achieved compelling pre-clinical results in the field of xenotransplantation.

Aging-US Releases "From Causes of Aging to Death from COVID-19"

Retrieved on: 
Wednesday, October 7, 2020
Gerontology, Demography, Ageing, Aging-associated diseases, Life extension, Evolution of ageing, Geroscience, Aging, Coronavirus disease, Death

ORCHARD PARK, N.Y., Oct. 7, 2020 /PRNewswire/ --Aging-US recently published "From Causes of Aging to Death from COVID-19" by Blagosklonny et al.

Key Points: 
  • ORCHARD PARK, N.Y., Oct. 7, 2020 /PRNewswire/ --Aging-US recently published "From Causes of Aging to Death from COVID-19" by Blagosklonny et al.
  • The hyperfunction theory of quasi-programmed aging explains why COVID-19 vulnerability is an age-dependent syndrome, linking it to other age-related diseases.
  • This is because pre-existing conditions are manifestations of biological age, ultimately meaning that A. aging and B. diseases are two sides of the same coin.
  • The Blagosklonny Research Team goes on to highlight that an anti-aging intervention, such as rapamycin , may slow aging and age-related diseases, potentially decreasing COVID-19 vulnerability.

RenovaCare Elects Alan L. Rubino to Chairman of the Board of Directors

Retrieved on: 
Monday, October 5, 2020
Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Cell biology, Life extension, Stem-cell therapy

Mr. Rubino replaces Harmel S. Rayat as Chairman of the Board, who resigned from the Board and as Chairman on the same date.

Key Points: 
  • Mr. Rubino replaces Harmel S. Rayat as Chairman of the Board, who resigned from the Board and as Chairman on the same date.
  • We wish Mr. Rayat continued success in his future business endeavors, concluded Mr. Rubino.
  • RenovaCare, Inc. is developing first-of-its-kind autologous (self-donated) stem cell therapies for the regeneration of human organs.
  • RenovaCare is developing its CellMist System as a promising new alternative for patients suffering from burns, chronic and acute wounds, and scars.

Global Anti-aging Treatment Market to Surpass US$ 34.49 Billion by 2027, Says Coherent Market Insights (CMI)

Retrieved on: 
Monday, October 5, 2020
Alternative medicine, General Health, Pharmaceutical, Health, Demography, Articles, Skin care, Academic disciplines, Life extension, Population, Cosmetics, Ageing, Beiersdorf

According to Coherent Market Insights, the global anti-aging treatment market is estimated to be valued at US$ 21.06 billion in 2020 and is expected to exhibit a CAGR of 7.3% over the forecast period (2020-2027).

Key Points: 
  • According to Coherent Market Insights, the global anti-aging treatment market is estimated to be valued at US$ 21.06 billion in 2020 and is expected to exhibit a CAGR of 7.3% over the forecast period (2020-2027).
  • Key Trends and Analysis of the Global Anti-aging Treatment Market:
    Key trends in the market include increasing launches of anti-aging treatment products, increasing number of aesthetic procedures, and increasing acquisitions, partnerships, and agreements by key players.
  • The global anti-aging treatment market is expected to exhibit a CAGR of 7.3% over the forecast period.
  • Key players operating in the global anti-aging treatment market include Allergan Plc, Este Lauder Companies, Shiseido Company, Beiersdorf AG, L'Oral S.A, NuFACE, Ostium Cosmetics, PhotoMedex, Inc, Alma Laser, Rodan & Fields, LLC, and others

Healthy Aging Medical Centers' New Location Now Open in Hazlet, New Jersey

Retrieved on: 
Thursday, October 1, 2020
Articles, Demography, Academic disciplines, Gerontology, Hazlet, Ageing, Health, Life extension

HAZLET, N.J., Oct. 1, 2020 /PRNewswire/ --Healthy Aging Medical Centers is proud to announce that they have opened a new location in Hazlet, New Jersey.

Key Points: 
  • HAZLET, N.J., Oct. 1, 2020 /PRNewswire/ --Healthy Aging Medical Centers is proud to announce that they have opened a new location in Hazlet, New Jersey.
  • Healthy Aging Medical Centers is a comprehensive Anti-AgingClinic in New Jersey that helps male and female patients regain hormonal balance while avoiding having to deal with a lot of the symptoms that come with hormonal decline that may interfere with everyday life.
  • If one is worried that their t-levels may be low or just want to be informed, they are encouraged to give Healthy Aging Medical Centers a call for a consultation.
  • Healthy Aging Medical Centers help their patients improve their health issues and improve their quality of life.

Male Enhancement Breakthrough at Dallas Clinic Grows in Popularity, Praise

Retrieved on: 
Tuesday, September 29, 2020
Demography, Articles, Academic disciplines, Ageing, Gerontology, Life extension, Population, Credence, Dallas, Aging of wine

DALLAS, Sept. 29, 2020 /PRNewswire/ -- Adding credence to the belief that size really does matter, a proprietary male enhancement method recently introduced at Dallas Anti-Aging & Wellness is gaining in popularity and plaudits from the men receiving it.

Key Points: 
  • DALLAS, Sept. 29, 2020 /PRNewswire/ -- Adding credence to the belief that size really does matter, a proprietary male enhancement method recently introduced at Dallas Anti-Aging & Wellness is gaining in popularity and plaudits from the men receiving it.
  • The benefits can last up to a year and a half, can be touched up to maintain size, and the results are non-permanent and reversible.
  • One recipient, J.P., asserted: "My experience from start to finish was excellent!
  • Dallas Anti-Aging & Wellness has noted that some men are flying in from as far away as 2,000 miles to receive the same-day treatment.

Histogen Announces Update for its HST-002 Dermal Filler Program

Retrieved on: 
Tuesday, September 29, 2020
Branches of biology, Senescence, Articles, Biology, Life extension, Healing, Cartilage, Connective tissue, Skeletal system, Regeneration, Rejuvenation, Osteochondritis dissecans

HST-001, if approved, could be a first-in-class product given its potential to stimulate new long-lasting hair growth in contrast to existing therapies that focus on reducing hair loss.

Key Points: 
  • HST-001, if approved, could be a first-in-class product given its potential to stimulate new long-lasting hair growth in contrast to existing therapies that focus on reducing hair loss.
  • In addition, we continue to make progress on our HST-003 program for regeneration of cartilage in the knee and anticipate filing an IND in the fourth quarter of 2020.
  • Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the bodys natural process to repair and maintain healthy biological function.
  • Histogens proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair.

New Report Shows Largest National Reduction in Beverage Calorie Consumption Since Launch of Landmark Beverage Agreement

Retrieved on: 
Monday, September 28, 2020
Articles, Health, Diets, Obesity, Food and drink, Nutrition, Calorie restriction, Life extension, Senescence, Sugar, Sugary drink tax

The report noted that 2019 saw the largest single-year reduction in calorie consumption and the third consecutive year of declines since the launch of the initiative.

Key Points: 
  • The report noted that 2019 saw the largest single-year reduction in calorie consumption and the third consecutive year of declines since the launch of the initiative.
  • According to the report, consumption of calories and sugar from beverages fell by 2.4% in 2019, even as sales volumes grew.
  • "We are pleased to see continued progress toward the 2025 beverage calorie reduction target," said Kathy Higgins, chief executive officer at Healthier Generation.
  • The Beverage Calories Initiative builds upon this effort to decrease consumption of calories from beverages at both a national and local level.

Global Anti-Aging Products Market (2020 to 2025) - Growth, Trends, and Forecast - ResearchAndMarkets.com

Retrieved on: 
Monday, September 28, 2020
Cosmetics, Retail, Ageing, Skin care, Demography, Cosmetics, Articles, Academic disciplines, Anti-aging cream, Life extension

Also, the high purchasing power of the customers from the developed and the developing countries contribute to surge the market growth.

Key Points: 
  • Also, the high purchasing power of the customers from the developed and the developing countries contribute to surge the market growth.
  • Thus, a wide range of anti-aging products is available in the market for different needs of the consumers, where anti-wrinkle products dominate the market, accounting for the majority of the total share.
  • The growth of anti-aging products in Asian countries including China, Japan, Singapore, India, and Australia is increasing significantly.
  • Consumers are seeking skincare products with oils, including blended formulations and pure organics, to provide healthy fixes for dry and damaged skin.

Swiss Medical Group Holding Acquires CoreMedica Europe

Retrieved on: 
Thursday, September 24, 2020
Pharmaceutical, Managed care, General Health, Health, FDA, Mental health, Medical devices, Other Health, Demography, Articles, Academic disciplines, Emerging technologies, Ageing, Gerontology, Old age, Life extension, Starks

Swiss Medical Group (SMG) Holding Luxembourg S.A., leading the development of STARKS Age-Management in Europe and Asia, announced today the acquisition of CoreMedica Europe, to expand in Europe and the rest of the world.

Key Points: 
  • Swiss Medical Group (SMG) Holding Luxembourg S.A., leading the development of STARKS Age-Management in Europe and Asia, announced today the acquisition of CoreMedica Europe, to expand in Europe and the rest of the world.
  • In this epidemic and containment context the essential objective of CoreMedica Europe is to allow a patient to collect a few drops of blood at home without involving healthcare personnel and to carry out this serology test in a controlled laboratory environment.
  • The objective of SMG is to integrate CoreMedica Europe's unique expertise in the field of blood tests and personalized recommendations into the network of anti-aging clinics that SMG is developing in Europe, so as to improve P4 models in the field of anti-aging and foster preventative care, thereby reducing the costs of treatments, says Francois Marland, Chairman and CEO of Swiss Medical Group and Chairman of CoreMedica Europe.
  • Following the merger with BioKaizen in 2018, CoreMedica expanded its offering globally to include personalized nutrition and sport performance information that empowers customers with information to help actively manage their health.